DK2289A - Monoklonale antistoffer samt deres fremstilling og anvendelse - Google Patents

Monoklonale antistoffer samt deres fremstilling og anvendelse

Info

Publication number
DK2289A
DK2289A DK002289A DK2289A DK2289A DK 2289 A DK2289 A DK 2289A DK 002289 A DK002289 A DK 002289A DK 2289 A DK2289 A DK 2289A DK 2289 A DK2289 A DK 2289A
Authority
DK
Denmark
Prior art keywords
antibodies
preparation
derivatives
monoclonal antibodies
therapy
Prior art date
Application number
DK002289A
Other languages
English (en)
Other versions
DK2289D0 (da
DK172440B1 (da
Inventor
Franz Buchegger
Jean-Pierre Mach
Original Assignee
Franz Buchegger
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Franz Buchegger, Res Corp Technologies Inc filed Critical Franz Buchegger
Publication of DK2289D0 publication Critical patent/DK2289D0/da
Publication of DK2289A publication Critical patent/DK2289A/da
Application granted granted Critical
Publication of DK172440B1 publication Critical patent/DK172440B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK198900022A 1988-01-05 1989-01-04 Monoklonale antistoffer og derivater deraf, fremgangsmåde til deres fremstilling, hybridomacellelinie og fremgangsmåde til DK172440B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888800078A GB8800078D0 (en) 1988-01-05 1988-01-05 Novel antibodies
GB8800078 1988-01-05

Publications (3)

Publication Number Publication Date
DK2289D0 DK2289D0 (da) 1989-01-04
DK2289A true DK2289A (da) 1989-07-06
DK172440B1 DK172440B1 (da) 1998-07-27

Family

ID=10629465

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198900022A DK172440B1 (da) 1988-01-05 1989-01-04 Monoklonale antistoffer og derivater deraf, fremgangsmåde til deres fremstilling, hybridomacellelinie og fremgangsmåde til

Country Status (12)

Country Link
US (1) US5047507A (da)
EP (1) EP0323805B1 (da)
JP (1) JPH025893A (da)
AT (1) ATE101202T1 (da)
AU (1) AU619232B2 (da)
CA (1) CA1315219C (da)
DE (1) DE3887675T2 (da)
DK (1) DK172440B1 (da)
ES (1) ES2061730T3 (da)
GB (1) GB8800078D0 (da)
IE (1) IE62439B1 (da)
PT (1) PT89385B (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0407392B2 (en) * 1987-12-31 1998-10-28 Tanox Biosystems, Inc. UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES
US5843708A (en) * 1988-01-05 1998-12-01 Ciba-Geigy Corporation Chimeric antibodies
GB8800077D0 (en) * 1988-01-05 1988-02-10 Ciba Geigy Ag Novel chimeric antibodies
AU634314B2 (en) * 1989-11-13 1993-02-18 Green Cross Corporation, The Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
GB9014932D0 (en) * 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
US5661016A (en) * 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
WO1993015405A1 (en) * 1992-01-29 1993-08-05 Sci-Clone, Inc. Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor
WO1993016193A1 (en) * 1992-02-14 1993-08-19 Suntory Limited Cell adhesion inhibiting antibody and cell adhesion inhibitor containing the same
CA2102294A1 (en) * 1992-03-10 1993-09-11 Jose L. Millan Recombinant calf intestinal alkaline phosphatase
US5502037A (en) * 1993-07-09 1996-03-26 Neuromed Technologies, Inc. Pro-cytotoxic drug conjugates for anticancer therapy
US5874540A (en) * 1994-10-05 1999-02-23 Immunomedics, Inc. CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
WO1996017252A1 (en) * 1994-11-28 1996-06-06 Abbott Laboratories Stabilized aqueous steroid immunoassay standards
US5648268A (en) * 1994-12-06 1997-07-15 Ibm Corporation Radionuclide exchange detection of ultra trace ionic impurities in water
US6207805B1 (en) 1997-07-18 2001-03-27 University Of Iowa Research Foundation Prostate cell surface antigen-specific antibodies
US6828157B1 (en) * 1999-05-04 2004-12-07 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US6682940B2 (en) * 1999-05-04 2004-01-27 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US6774209B1 (en) * 2000-04-03 2004-08-10 Dyax Corp. Binding peptides for carcinoembryonic antigen (CEA)
DE20105649U1 (de) * 2001-03-30 2001-08-16 Wang, Ming-Theng, Chungho, Taipeh Kettenzahnrad und Ratschenanordnung geringer Reibung für die rückwärtige Nabe eines Zweirades
EP2662211A1 (en) * 2002-06-24 2013-11-13 Tufts University Silk biomaterials and methods of use thereof
EP1572131B1 (en) 2002-10-08 2016-07-06 Immunomedics, Inc. Antibody therapy
WO2004062697A2 (en) 2003-01-07 2004-07-29 Tufts University Silk fibroin materials and use thereof
CA2562415C (en) * 2003-04-10 2015-10-27 Tufts University Concentrated aqueous silk fibroin solutions free of organic solvents and uses thereof
WO2005000483A1 (en) * 2003-06-06 2005-01-06 Tufts University Method for forming inorganic coatings
JP2006214765A (ja) * 2005-02-01 2006-08-17 Bml Inc ヒトＡｐｏＡ−Ｖ蛋白質に対する抗体、及び、当該抗体を用いたヒトＡｐｏＡ−Ｖ蛋白質定量測定系
EP2129772B1 (en) 2007-02-27 2016-07-27 Trustees Of Tufts College Tissue-engineered silk organs
ES2527125T3 (es) 2007-05-29 2015-01-20 Trustees Of Tufts College Método para la gelificación de fibroína de seda usando sonicación
CA2713251A1 (en) * 2008-02-07 2009-08-13 Trustees Of Tufts College 3-dimensional silk hydroxyapatite compositions
WO2009140588A1 (en) * 2008-05-15 2009-11-19 Trustees Of Tufts College Silk polymer-based adenosine release: therapeutic potential for epilepsy
AU2009302192B2 (en) 2008-06-18 2014-08-28 Trustees Of Tufts College Modified silk films containing glycerol
US8501172B2 (en) 2008-09-26 2013-08-06 Trustees Of Tufts College pH-induced silk gels and uses thereof
WO2011008842A2 (en) 2009-07-14 2011-01-20 Trustees Of Tufts College Electrospun silk material systems for wound healing
JP2013506058A (ja) 2009-09-28 2013-02-21 タフツ ユニバーシティー／トラスティーズ オブ タフツ カレッジ 延伸したシルクｅｇｅｌ繊維およびその製造方法
JP5730317B2 (ja) 2009-09-29 2015-06-10 タフツ ユニバーシティー／トラスティーズ オブ タフツ カレッジ 絹ナノスフェアおよび絹マイクロスフェアならびにこれらを作製する方法
WO2011109691A2 (en) 2010-03-05 2011-09-09 Trustees Of Tufts College Silk-based ionomeric compositions
EP2611473A4 (en) 2010-09-01 2014-08-13 Tufts College BIOMATERIALS BASED ON SILK FIBROIN AND POLYETHYLENE GLYCOL
EP2629836B1 (en) 2010-10-19 2018-09-12 Trustees Of Tufts College Silk fibroin-based microneedles and methods of making the same
CA2817380C (en) 2010-12-16 2019-06-04 Genentech, Inc. Diagnosis and treatments relating to th2 inhibition
WO2012145652A1 (en) 2011-04-20 2012-10-26 Trustees Of Tufts College Dynamic silk coatings for implantable devices
WO2013119551A1 (en) 2012-02-06 2013-08-15 Children's Medical Center Corporation Multi-layer biomaterial for tissue regeneration and wound healing
KR101819404B1 (ko) 2012-10-12 2018-02-28 메디뮨 리미티드 피롤로벤조디아제핀 및 그의 컨주게이트
JP6444902B2 (ja) 2013-03-13 2018-12-26 メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ ピロロベンゾジアゼピン及びその結合体
CN106687141A (zh) 2014-09-10 2017-05-17 麦迪穆有限责任公司 吡咯并苯并二氮杂卓及其缀合物
US20200023072A1 (en) 2016-10-11 2020-01-23 Medimmune Limited Antibody-drug conjugates with immune-mediated therapy agents
EP3796942A1 (en) 2018-05-23 2021-03-31 ADC Therapeutics SA Molecular adjuvant
US20230372528A1 (en) 2020-10-16 2023-11-23 University Of Georgia Research Foundation, Inc. Glycoconjugates
GB202102396D0 (en) 2021-02-19 2021-04-07 Adc Therapeutics Sa Molecular adjuvant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361544A (en) * 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
JPH0811075B2 (ja) * 1982-06-30 1996-02-07 雄治 松岡 単クローン性抗ｃｅａ抗体
WO1984002983A1 (en) * 1983-01-21 1984-08-02 Frederick James Primus Specific cea-family antigens, antibodies specific thereto and their methods of use
DE3531301A1 (de) * 1985-09-02 1987-03-05 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte glykoproteine, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
CA1315219C (en) 1993-03-30
PT89385A (pt) 1990-02-08
ES2061730T3 (es) 1994-12-16
DK2289D0 (da) 1989-01-04
IE890018L (en) 1989-07-05
EP0323805A3 (en) 1990-04-25
US5047507A (en) 1991-09-10
ATE101202T1 (de) 1994-02-15
JPH025893A (ja) 1990-01-10
AU619232B2 (en) 1992-01-23
DK172440B1 (da) 1998-07-27
EP0323805A2 (en) 1989-07-12
GB8800078D0 (en) 1988-02-10
DE3887675T2 (de) 1994-06-30
PT89385B (pt) 1993-09-30
EP0323805B1 (en) 1994-02-02
DE3887675D1 (de) 1994-03-17
IE62439B1 (en) 1995-02-08
AU2739188A (en) 1989-07-06

Similar Documents

Publication Publication Date Title
DK2289D0 (da) Monoklonale antistoffer samt deres fremstilling og anvendelse
EP0265500A4 (en) ANTIBODIES AGAINST HUMAN PROGESTERONE RECEPTOR AND DIAGNOSTIC PRODUCTS AND METHOD.
DK40885D0 (da) Monoklonalt antistof, fremgangsmaade og celle til fremstilling deraf,fremgangsmaade til fremstilling af cellen og farmaceutisk praeparat indeholdende det monoklonale antistof
PT744958E (pt) Bancos de anticorpos policlonais
MY108526A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
NO985150L (no) Antigenbindingsfragmenter som spesifikt detekterer cancerceller, nukleotider som koder fragmentene samt anvendelse derav for profylakse og deteksjon av cancere
ES2053810T3 (es) Nuevos anticuerpos quimericos.
DE68925226D1 (de) Monoklonale Antikörper
FI950062A (fi) Proteiinien foroaktivaatio konjugaatiotarkoituksia varten
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
EP0352722A3 (en) Adenocarcinoma antigen binding methods and reagents
EP0232871A3 (en) Human monoclonal antibody, hybridoma producing the same and its use
WO1999002545A3 (en) Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
FI900230A0 (fi) Anti-idiotypa antikroppar mot antikroppar mot antigener med hoeg molekylvikt associerade till human melanoma.
DK314586A (da) Monoklonale antistoffer og antigener for humane lungecarcinomer, der ikke er af typen med smaa celler
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
DE69030494D1 (de) Karzinomverwandtes haptoglobin (hpr)
ES2052913T3 (es) Ensayo inmunoquimico en cuanto al factor estimulante de colonias de granulocitos-macrofagos.
DE3582191D1 (de) Verwendung eines spezifischen karzinomassoziierenden antigens (hapten), fucosylsialosylgangliotetrose (fuc-gm1) in diagnostischen und therapeutischen verfahren betreffend den menschlichen lungenkrebs (carcinomas von kleinen zellen).
ZA884777B (en) Antigen recognized by mca 16 88
IL67944A0 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same
NO914094L (no) Nytt monoklonalt antistoff mot nytt antigen forbundet medhumantumorer
NO176903C (no) Antistoff eller bindende fragment derav til diagnostikk av humant carcinom, eller som transportör av farmasöytiske midler, isolert, humant tumor-assosiert antigen, diagnostisk middel og fremgangsmåte for in vitro-diagnostisering
ATE95426T1 (de) Humanes karcinom-assoziertes antigen und an dieses antigen bindende antikoerper.
DK182188A (da) Humant tumorassocieret antigen

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed